Right choice is (d) 20-50 people
For explanation: Phase I trials are the first stage of testing in human subjects. Normally, a small group of 20-50 healthy volunteers will be selected. This phase includes trials designed to assess the safety (pharmacovigilance), tolerability, pharmacokinetics, and pharmacodynamics of a drug. Phase 2 trial will be done on 20-300 people. Phase 3 trial will be done on 300-3000 people.